Here’s an item of interest that may have gone unnoticed: The Food and Drug Administration (FDA) last week issued a call for public comment on a proposed study of infant formula label statements, such as “supports brain and eye development.”
According to its posting in the Federal Register, the purpose of the study is to “assess women’s understanding of and response to various statements on infant formula labels.” The study will involve a survey of four groups:
- pregnant women
- mothers of infants less than 12 months old
- mothers of children >1 and <5 years old
- women of childbearing age with no children <5 years old
An online consumer panel will randomly select 5,000 participants who meet this criteria; for more details about study details, including what types of questions will be included, see the agency’s notice. The results will “help the Agency understand the role that certain types of statements on infant formula labels have in influencing choice.”
If you are concerned about the addition of DHA and ARA to infant formula and support the FDA’s proposed study, let them know before May 2nd. Submit comments electronically or send them to Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments must refer to Docket No. FDA-2011-N-0098.